Mitral valve therapy device, system and method

Abstract

An assembly and method for effecting the condition of a mitral valve annulus of a heart includes a guide wire configured to be fed into the coronary sinus of the heart, and a mitral valve annulus therapy device configured to be slidingly received on the guide wire and advanced into the coronary sinus of the heart on the guide wire. A guide tube may further be employed for guiding the device into the coronary sinus. An introducer which may be employed for pushing the device into or pulling device out of the heart has a mechanism for releasably locking to the device. This enables substitution of the device if needed. Also, the crossover point of the circumflex artery and coronary sinus may be determined and avoided when the device is deployed.

Description

FIELD OF THE INVENTION [0001] The present invention generally relates to a device, system and method for treating a deformed heart valve. The present invention more particularly relates to a device, system and method for constricting or reforming a mitral valve annulus from within the coronary sinus to correct mitral valve dilation without blocking blood flow in the circumflex artery and which may be implemented using a guide wire within the coronary sinus to effect accurate device deployment and substitution. BACKGROUND OF THE INVENTION [0002] The human heart generally includes four valves. Of these valves, a most critical one.. is known as the mitral valve. The mitral valve is located in the left atrial ventricular opening between the left atrium and left ventricle. The mitral valve is intended to prevent regurgitation of blood from the left ventricle into the left atrium when the left ventricle contracts. In preventing blood regurgitation the mitral valve must be able to withstan...

AI Technical Summary

Problems solved by technology

The normal functioning of the mitral valve in preventing regurgitation can be impaired by dilated cardiomyopathy caused by disease or certain natural defects.

This can result in deformation of the mitral valve geometry to cause ineffective closure of the mitral valve during left ventricular contraction.

Such ineffective closure results in leakage through the mitral valve and regurgitation.

Diseases such as bacterial inflammations of the heart or heart failure can cause the aforementioned distortion or dilation of the mitral valve annulus.

While the replacement of the entire valve eliminates the immediate problem associated with a dilated mitral valve annulus, presently available prosthetic heart valves do not possess the same durability as natural heart valves.

While the prior art methods mentioned above have been able to achieve some success in treating mitral regurgitation, they have not been without problems and potential adverse consequences.

Such procedures are expensive, are extremely invasive requiring considerable recovery time, and pose the concomitant mortality risks associated with such procedures.

Moreover, such open heart procedures are particularly stressful on patients with a comprised cardiac condition.

Further, the effectiveness of such procedures is difficult to assess during the procedure and may not be known until a much later time.

Hence, the ability to make adjustments to or changes in the prostheses to obtain optimum effectiveness is extremely limited.

Unfortunately, the human anatomy does impose some obstacles to this recently proposed procedure for treating mitral regurgitation.

As a result, a device placed in the coronary sinus must not be permitted to extend within the coronary sinus beyond the crossover point of the circumflex artery and the coronary sinus to avoid constriction of the circumflex artery.

Images